⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Shareholders to Inquire about Securities Investigation
accessnewswire.com
ALVO
Levi & Korsinsky Launches Fraud Investigation on Behalf of Alvotech (ALVO) Shareholders
accessnewswire.com
ALVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
prnewswire.com
ALVO
ATTENTION ALVO Investors: Securities Fraud Investigation Underway – Contact Levi & Korsinsky
accessnewswire.com
ALVO
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
globenewswire.com
ALVO
Alvotech og Advanz Pharma fá markaðsleyfi á Evrópska efnahagssvæðinu fyrir Gobivaz, fyrstu hliðstæðuna við Simponi
globenewswire.com
ALVO
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
globenewswire.com
ALVO
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
businesswire.com
ALVO
Potential Securities Fraud: Levi & Korsinsky Investigates Alvotech (ALVO)
accessnewswire.com
ALVO
ALVO ALERT: Ongoing Investigation Into Alvotech - Contact Levi & Korsinsky
accessnewswire.com
ALVO